All In MedTech

Device Trial Radar · NCT06475677

OrthoCor Advanced Trial for Knee Osteoarthritis

Prospective Trial of the OrthoCor Advanced System for Patients With Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Dec 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

23

Actual

Start

Jun 18, 2024

Primary completion

Oct 6, 2025

Study completion Oct 6, 2025

Sponsor

Lead sponsor
Caerus CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jun 26, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this clinical trial is to show that PEMF therapy, heat, recovery metrics, and compliance data provided by the OrthoCor Advanced System improves pain and quality of life for patients with osteoarthritis. The main question it aims to answer is: Does therapy from the OrthoCor Advanced System improve symptoms of osteoarthritis? Researchers will compare range of motion measurements, sit to stand test results, and functional survey answers to see if there are any changes after 4 weeks of therapy with the OrthoCor Advanced System. Participants will use the OrthoCor Active System for 30 minutes twice daily and complete recovery measurements daily using an application.

Conditions

  • Osteoarthritis, Knee
  • Osteo Arthritis Knee

Interventions

  • OrthoCor Advanced SystemDevice

    The OrthoCor Advanced System is a portable battery-operated non-invasive device that delivers Pulsed Electromagnetic Field (PEMF) plus heat therapy for general use pain relief. It utilizes a wrap that positions the device over painful areas and joint motion tracking recorded by a smart device application to monitor recovery metrics and therapy compliance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: during 4 weeks of treatment
  2. VAS pain scoreTime frame: before, during, and after 4 weeks of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Andrews Research & Education Foundation

    Gulf Breeze, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.